ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ACRS announcements Aclaris Therapeutics, Inc. announcements and dividends declared NASDAQ

Aclaris Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Aclaris Therapeutics, Inc. ACRS

Aclaris Therapeutics, Inc. ACRS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Aclaris Therapeutics, Inc. ACRS

Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics
Sun Pharmaceutical Industries Ltd on Wednesday said its arm has entered into a licensing agreement with Aclaris Therapeutics, Inc that includes upfront payment of USD 15 million (about Rs 125 crore), regulatory and commercial milestones, and royalties. The
Announcement as on 06 December 2023

Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreement
As per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or other isotopic forms of ruxolitinib, specifically for treating alopecia areata (AA) or androgenetic alopecia (AGA).
Announcement as on 06 December 2023

Sun Pharma subsidiary announces licensing pact with Aclaris Therapeutics
Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases
Announcement as on 06 December 2023

Aclaris Therapeutics stock more than triples after 'positive' data on arthritis treatment trial
Shares of Aclaris Therapeutics Inc. skyrocketed more than 200% toward a 2 1/2-year high, on massive volume, in midday trading Tuesday, after the biopharmaceutical company announced "positive" data from a Phase 2a trial of its rheumatoid arthritis treatmen
Announcement as on 19 January 2021

Aclaris Therapeutics stock triples after positive data on arthritis treatment
Aclaris Therapeutics stock triples after positive data on arthritis treatment
Announcement as on 19 January 2021

Announcements by Aclaris Therapeutics, Inc. first page | Next page |

ACRS Aclaris Therapeutics, Inc. current price & indicator signals

Moving Averages for Aclaris Therapeutics, Inc.

  • 5Day Average: 2.8
  • 12Day Average: 2.72
  • 20Day Average: 2.58
  • 50Day Average: 2.29
  • 100Day Average: 2.04
  • 150Day Average: 1.83
  • 200Day Average: 1.75

ACRS Indicators & signals

Indicator MACD (12,26,9)

2.73, 2.57, 0.14
Indicator MACD is in positive zone

Indicator ADX (14)

6.67, 36.36, 31.82
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ACRS Aclaris Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 2.92 2.90 to 3.03 -2.99% 0.72 times
04 Thu Dec 2025 3.01 2.72 to 3.08 8.27% 1.4 times
03 Wed Dec 2025 2.78 2.66 to 2.90 2.96% 0.73 times
02 Tue Dec 2025 2.70 2.59 to 2.74 3.45% 1.24 times
01 Mon Dec 2025 2.61 2.61 to 2.82 -7.77% 1.05 times
28 Fri Nov 2025 2.83 2.76 to 2.92 -1.74% 0.44 times
26 Wed Nov 2025 2.88 2.70 to 2.90 5.49% 1.1 times
25 Tue Nov 2025 2.73 2.65 to 2.77 -0.73% 0.72 times
24 Mon Nov 2025 2.75 2.46 to 2.78 9.56% 1.79 times
21 Fri Nov 2025 2.51 2.34 to 2.56 4.15% 0.78 times
20 Thu Nov 2025 2.41 2.39 to 2.57 -2.03% 0.74 times
19 Wed Nov 2025 2.46 2.41 to 2.55 -1.2% 0.67 times

Videos related to: ACRS announcements Aclaris Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ACRS announcements Aclaris Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top